<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Multilineage <z:mpath ids='MPATH_589'>dysplasia</z:mpath> was advanced by the World Health Organization to increase prognostic accuracy in <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) classification </plain></SENT>
<SENT sid="1" pm="."><plain>We performed a structured cytomorphological examination of bone marrow (BM) in 221 low-grade <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients, this in conjunction with strict guidelines for cytopenias </plain></SENT>
<SENT sid="2" pm="."><plain>A <z:mpath ids='MPATH_589'>dysplasia</z:mpath> scoring system was developed utilizing dysplastic changes, which were associated with worse outcome on univariate and multivariate analysis corrected for the International Prognostic Scoring System (IPSS) </plain></SENT>
<SENT sid="3" pm="."><plain><z:mpath ids='MPATH_589'>Dysplasia</z:mpath> &gt;or=10% in one BM lineage and one cytopenia constituted the low-risk category UCUD or Unilineage Cytopenia and Unilineage <z:mpath ids='MPATH_589'>Dysplasia</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain>The high-risk category comprised patients with cytopenia in &gt;or=2 lineages and <z:mpath ids='MPATH_589'>dysplasia</z:mpath> in &gt;or=2 BM lineages, namely MCMD or Multilineage Cytopenia and Multilineage <z:mpath ids='MPATH_589'>Dysplasia</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>Intermediate-risk patients had one cytopenia and multilineage <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, or cytopenia in &gt;or=2 lineages and unilineage BM <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, designated UCMD/MCUD or Unilineage Cytopenia and Multilineage <z:mpath ids='MPATH_589'>Dysplasia</z:mpath>/Multilineage Cytopenia and Unilineage <z:mpath ids='MPATH_589'>Dysplasia</z:mpath> </plain></SENT>
<SENT sid="6" pm="."><plain>This system utilizing cytopenia-<z:mpath ids='MPATH_589'>dysplasia</z:mpath> scoring at diagnosis enabled comprehensive categorization of low-grade <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> cases that predicted for overall as well as <z:hpo ids='HP_0001909'>leukemia</z:hpo>-free survival </plain></SENT>
<SENT sid="7" pm="."><plain>Cytopenia-<z:mpath ids='MPATH_589'>dysplasia</z:mpath> categorization added additional prognostic values to the lower risk IPSS categories </plain></SENT>
<SENT sid="8" pm="."><plain>This suggests that a standardized <z:mpath ids='MPATH_589'>dysplasia</z:mpath> scoring system, used in conjunction with cytopenia, could improve diagnostic and prognostic sub-categorization of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients </plain></SENT>
</text></document>